Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sorrento Therapeutics, Inc. - Common Stock (NQ: SRNE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sorrento Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
SRNE Stock: The Big News Lifting Sorrento Therapeutics Today
Today, SRNE stock is on the move in a big way as investors price in two key announcements made by the company regarding clinical trials. 
Via InvestorPlace
Sorrento, Mayo Clinic Ink Research Pact For Ipilimumab-Delivering Sofusa In Melanoma Patients
Sorrento Therapeutics Inc (NASDAQ: SRNE) entered into a research collaboration agreement with Mayo Clinic to conduct human clinical proof of concept studies using... 
Via Benzinga
Sorrento Therapeutics Starts Large Efficacy Trial For Intranasal COVID-19 Antibody In UK
The U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) signed off Sorrento Therapeutics Inc's (NASDAQ: SRNE) Phase 2 trial evaluating COVI-... 
Via Benzinga
Exposures COVID-19
Market Briefing For Tuesday, Jun. 8
Benign market behavior generally persists; as an out-of-the-box rally effort to start Monday was reversed, as is typical since traders want a pullback first. 
Via Talk Markets
Why The Relaxation In Lockdowns Is Expected To Drive The Demand For COVID-19 Diagnostics Market
Via FinancialNewsMedia
Exposures COVID-19
Why Sorrento Therapeutics Is Trading Higher Today
Sorrento Therapeutics Inc (NASDAQ:SRNE) is trading higher ... 
Via Benzinga
Market Briefing For Thursday, Jun. 3
Winding down the stimulative structures dominant during the pandemic, will be a huge challenge; something the Fed is keenly aware (and fearful) of. The move today to slightly trim a corporate lending... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
66 Biggest Movers From Yesterday
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) surged 95.2% to close at $62.55 on Wednesday amid renewed interest from retail investors. AMC Entertainment shares jumped... 
Via Benzinga
Why Sorrento Therapeutics Stock Surged Today
The biotech could play an important role in the battle against cancer and autoimmune diseases. 
Via The Motley Fool
Sorrento Therapeutics Looks Like It May Have Broken Out Of A Falling Wedge Pattern
Sorrento Therapeutics Inc. (NASDAQ:SRNE) shares are tradin... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Constellation (NASDAQ:CNST) shares rose 67.19% to $33.84 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 19.5... 
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously... 
Via Benzinga
Market Briefing For Wednesday, Jun. 2
Modest tightening not just by the US Fed (eventually) but by markets all by themselves as they perceive 'snugging-up' of global liquidity in 2021's second half, might well be a concern for the foreign... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Market Briefing For Tuesday, May 25
Seasonal bias kicked-in, to the upside, ahead of Memorial Day, primarily it seems led by rotational rebounds in the usual suspects of momentum stocks, but also as Oil moved above 65 / bb,; suggesting... 
Via Talk Markets
Sorrento Reports Encouraging Data From Sofusa-Administered Enbrel In Rheumatoid Arthritis
Sorrento Therapeutics Inc (NASDAQ: SRNE) reported positive initial results from the Phase 1B study of its Sofusa Lymphatic Delivery System administering Amgen... 
Via Benzinga
Market Briefing For Thursday, May 6
Wednesday was fairly stock specific (Peleton etc.), as well pharma, as the White House decided to vanquish vaccine IP rights, slapping those stocks counting on years-long revenue streams. Oils and... 
Via Talk Markets
Market Briefing For Wednesday, May 5
Janet Yellen said 'interest rates may need to rise moderately', and that's a part of the backdrop, though S&P has been set-up for decline for awhile. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Market Briefing For Wednesday, Apr. 28
Tactical behavior requires no change whatsoever. Just recognize that signs of an impending 'big-cap' correction are rising, with less erosion probably in a slew of small-cap stocks that have already... 
Via Talk Markets
Sorrento To Start Testing STI-3031 In Patients With Advanced Urothelial Carcinoma
The FDA has signed off Sorrento Therapeutics Inc's (NASDAQ: SRNE) IND to proceed with a Phase 2a study for STI-3031 for advanced urothelial carcinoma. STI... 
Via Benzinga
Exposures Product Safety
Why Sorrento Therapeutics' Stock Is Trading Higher Today
Sorrento Therapeutics (NASDAQ: SRNE) shares are trading higher after the company received FDA clearance to proceed with its Phase 2 study for Sti-3031 in advanced urothelial... 
Via Benzinga
Exposures Product Safety
Why Sorrento Therapeutics Stock Is Soaring Today
Hint: It's not because of anything the company said or did. 
Via The Motley Fool
Cramer Shares His Thoughts On Ferrari, Palantir And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Ferrari N.V. (NYSE: RACE) is just fabulous. He is a buyer of the stock. Cramer wouldn't hang around... 
Via Benzinga
Market Briefing For Monday, Apr. 26
Nasdaq is perking up, primarily led by FANG types reporting next week (discounted). So, higher a bit near-term; then, risks. 
Via Talk Markets
Sorrento's Human Derived Mesenchymal Stem Cells Achieves 100% Discharge Rate In Critically-Ill COVID-19 Patients
Sorrento Therapeutics Inc (NASDAQ: SRNE) has announced data from its Phase 1b study of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC)... 
Via Benzinga
Exposures COVID-19
Market Briefing For Monday, April 19
Next week should see consolidation and upside, and then correction risk rises. We're cautious and looking for a setback, but not catastrophe ahead. 
Via Talk Markets
Sorrento Therapeutics Stock Looks To Form Bullish Falling Wedge
Sorrento Therapeutics Inc. (NASDAQ: SRNE) shares lost ground Monday with no evident explanation. The stock was trending on StockTwits. Sorrento Therapeutics was down 7.... 
Via Benzinga
Week In Review: Sorrento Acquires ACEA In $488 Million Deal Between Two San Diego-China Oncology Biopharmas
Sorrento Therapeutics will acquire ACEA Therapeutics in a deal worth up to $488 million. Both companies develop novel cancer drugs, both are headquartered in San Diego and both have operations in... 
Via Talk Markets
SORRENTO INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sorrento Therapeutics, Inc. - SRNE
From Kahn Swick & Foti, LLC
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.